Search Results 931-940 of 16376 for pharmacogenetics
The main goal of this study is to evaluate whether a certain set of memory and thinking tests that are in English also work in other languages after they are ...
The purpose of this study is to collect blood samples for DNA analysis from patients clinically diagnosed with Alzheimers disease, Lewy Body disease, and ...
William "Harvey" case, chief executive officer, Carteret Health Care, shares the value of the clinical collaboration with Mayo Clinic is keeping more ...
Learn about postdoctoral education opportunities in Mayo Clinic's Molecular Pharmacology of G Protein-Coupled Receptors Lab led by Laurence J. Miller, M.D..
A Study to Describe Patterns of Treatment, Demographics, Clinical Characteristics, and Overall Survival in Patients with Unresectable or Metastatic Melanoma.
This phase II trial studies how well olaparib works in treating patients with biliary tract cancer that has spread to other places in the body (metastatic) and ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic researchers found a potential way to improve access for patients with end-stage kidney disease to hemodialysis. Latest stories.
ROCHESTER, Minn. — Mayo Clinic has been selected to lead a groundbreaking research project focused on improving indoor air quality and safety in healthcare ...
Researchers are leading the nation in developing powerful and precise radiopharmaceutical theranostics intended to treat people with deadly cancers.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.